William Valle

Board Director

Director

TriSalus Life Sciences, Inc.American Oncology Network, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€106k

▼ Sales (0 ops.)

—

Latest filing published 15 May 2026 for TriSalus Life Sciences, Inc.. Read the official filing

Filing timeline

BuySale

William Valle

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-32.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

William Valle: trading record in brief

Filings by William Valle span 2 companies, the busiest being American Oncology Network, Inc. and TriSalus Life Sciences, Inc. We count 4 filings; the first trade dates from 4 May 2024 and the latest from 14 May 2026.

On the market, this insider has only ever bought: 1 purchase, €106k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants. In 2026 alone, the filings show 1 purchase and no sales.

The newest entry dates from 15 May 2026: a share grant, in TriSalus Life Sciences, Inc. The last insider purchase was made public on 23 February 2026, 237 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.